REGENERON PHARMACEUTICALS $266.97

up +2.31


17/5/2013 07:17 PM  |  NASDAQ : REGN  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
5/2/2012 GOLDBERG MURRAY A SVP Finance and Admin CFO Trea -11,212 $136.37 -9.66%
5/2/2012 GOLDBERG MURRAY A SVP Finance and Admin CFO Trea 29,000 $21.92 31.63%
5/2/2012 GOLDBERG MURRAY A SVP Finance and Admin CFO Trea -1,200 $134.64 -1.38%
5/2/2012 GOLDBERG MURRAY A SVP Finance and Admin CFO Trea -600 $135.33 -0.70%
5/2/2012 GOLDBERG MURRAY A SVP Finance and Admin CFO Trea -800 $136.63 -0.94%
5/2/2012 GOLDBERG MURRAY A SVP Finance and Admin CFO Trea -1,355 $137.52 -1.60%
5/2/2012 GOLDBERG MURRAY A SVP Finance and Admin CFO Trea 25,438 $21.92 31.73%
5/2/2012 GOLDBERG MURRAY A SVP Finance and Admin CFO Trea -2,990 $138.28 -3.60%
5/2/2012 GOLDBERG MURRAY A SVP Finance and Admin CFO Trea -4,088 $136.37 -3.87%
5/2/2012 GOLDBERG MURRAY A SVP Finance and Admin CFO Trea -9,835 $136.37 -9.69%
5/1/2012 YANCOPOULOS GEORGE EVP CSO President Regeneron Re -20,120 $134.54 -2.32%
5/1/2012 YANCOPOULOS GEORGE EVP CSO President Regeneron Re -100 $133.95 -0.01%
5/1/2012 SCHLEIFER LEONARD S President & CEO -100 $136.57 -0.03%
5/1/2012 SCHLEIFER LEONARD S President & CEO -39,106 $135.29 -12.01%
5/1/2012 SCHLEIFER LEONARD S President & CEO -58,494 $134.55 -15.23%
5/1/2012 SCHLEIFER LEONARD S President & CEO -2,300 $133.86 -0.60%
5/1/2012 YANCOPOULOS GEORGE EVP CSO President Regeneron Re -12,945 $135.29 -1.53%
5/1/2012 Aberman Michael S VP Strategy and Investor Relat -3,862 $134.52 -23.90%
5/1/2012 Aberman Michael S VP Strategy and Investor Relat -2,300 $135.29 -18.70%
4/30/2012 Van Plew Daniel P SVP & General Mgr Industrial O -1,299 $135.94 -5.41%
4/30/2012 Van Plew Daniel P SVP & General Mgr Industrial O -13,143 $136.42 -57.87%
4/30/2012 Aberman Michael S VP Strategy and Investor Relat 12,500 $24.00 125.00%
4/30/2012 Aberman Michael S VP Strategy and Investor Relat -2,168 $138.31 -9.64%
4/30/2012 Aberman Michael S VP Strategy and Investor Relat -4,170 $138.31 -20.51%
4/27/2012 Van Plew Daniel P SVP & General Mgr Industrial O 30,432 $20.90 636.12%
4/27/2012 Van Plew Daniel P SVP & General Mgr Industrial O -4,596 $138.36 -13.05%
4/27/2012 Van Plew Daniel P SVP & General Mgr Industrial O -11,394 $138.36 -37.21%
4/27/2012 Van Plew Daniel P SVP & General Mgr Industrial O 4,784 $20.90 24.88%
4/19/2012 BAKER CHARLES A Director -12,910 $125.00 -57.38%
4/19/2012 BAKER CHARLES A Director 12,910 $18.80 134.62%
4/17/2012 BAKER CHARLES A Director 2,090 $18.80 21.79%
4/17/2012 BAKER CHARLES A Director -2,090 $125.00 -17.89%
3/26/2012 YANCOPOULOS GEORGE EVP CSO President Regeneron Re -1,010 $121.09 -0.12%
3/26/2012 YANCOPOULOS GEORGE EVP CSO President Regeneron Re -32,140 $120.21 -3.57%
3/26/2012 GOLDSTEIN JOSEPH L Director -5,000 $120.00 -100.00%
3/15/2012 GOLDSTEIN JOSEPH L Director -4,600 $110.77 -100.00%
3/15/2012 GOLDSTEIN JOSEPH L Director -400 $111.06 -100.00%
3/15/2012 GOLDSTEIN JOSEPH L Director -5,000 $115.00 -100.00%
3/1/2012 BROWN MICHAEL S Director 4,374 $19.69 29.83%
3/1/2012 BROWN MICHAEL S Director -4,374 $102.65 -22.98%
3/1/2012 BROWN MICHAEL S Director 626 $19.69 4.27%
3/1/2012 BROWN MICHAEL S Director -626 $103.01 -4.09%
3/1/2012 BROWN MICHAEL S Director 5,000 $15.80 34.10%
3/1/2012 BROWN MICHAEL S Director -5,000 $103.06 -25.43%
3/1/2012 BROWN MICHAEL S Director 7,300 $19.69 49.79%
3/1/2012 BROWN MICHAEL S Director -7,300 $103.39 -33.24%
3/1/2012 BROWN MICHAEL S Director 2,700 $19.69 18.41%
3/1/2012 BROWN MICHAEL S Director -2,700 $104.32 -15.55%
2/23/2012 SHOOTER ERIC M Director -400 $104.05 -100.00%
2/23/2012 SHOOTER ERIC M Director -9,600 $103.51 -96.00%
2/22/2012 Powchik Peter SVP Clinical Development & Reg -4,200 $94.71 -6.52%
2/22/2012 Powchik Peter SVP Clinical Development & Reg -10,800 $95.46 -17.94%
2/22/2012 Powchik Peter SVP Clinical Development & Reg -23,454 $96.45 -47.48%
2/22/2012 Powchik Peter SVP Clinical Development & Reg -9,600 $97.58 -37.00%
2/22/2012 Powchik Peter SVP Clinical Development & Reg -1,200 $98.05 -7.34%
2/21/2012 Powchik Peter SVP Clinical Development & Reg 49,428 $15.64 326.39%
2/21/2012 Powchik Peter SVP Clinical Development & Reg -7,705 $100.32 -11.93%
2/21/2012 Powchik Peter SVP Clinical Development & Reg -18,530 $100.32 -32.58%
2/21/2012 Powchik Peter SVP Clinical Development & Reg 20,000 $20.32 52.17%
2/21/2012 Powchik Peter SVP Clinical Development & Reg -4,050 $100.32 -6.94%
2/21/2012 Powchik Peter SVP Clinical Development & Reg -7,347 $100.32 -13.53%
2/21/2012 Powchik Peter SVP Clinical Development & Reg 25,438 $21.92 54.19%
2/21/2012 Powchik Peter SVP Clinical Development & Reg -5,558 $100.32 -7.68%
2/21/2012 Powchik Peter SVP Clinical Development & Reg -9,158 $100.32 -13.71%
2/21/2012 Powchik Peter SVP Clinical Development & Reg 15,000 $16.80 26.01%
2/21/2012 Powchik Peter SVP Clinical Development & Reg -2,511 $100.32 -3.46%
2/21/2012 Powchik Peter SVP Clinical Development & Reg -5,753 $100.32 -8.20%
2/16/2012 McCorkle Douglas S VP Controller and Asst Treasur -5,353 $107.50 -100.00%
2/15/2012 YANCOPOULOS GEORGE EVP CSO President Regeneron Re 129,902 $8.50 15.59%
2/15/2012 YANCOPOULOS GEORGE EVP CSO President Regeneron Re -10,103 $109.29 -1.05%
2/15/2012 YANCOPOULOS GEORGE EVP CSO President Regeneron Re -55,191 $109.29 -5.79%
2/15/2012 YANCOPOULOS GEORGE EVP CSO President Regeneron Re 3,430 $8.50 0.38%
2/15/2012 YANCOPOULOS GEORGE EVP CSO President Regeneron Re -266 $109.29 -0.03%
2/15/2012 YANCOPOULOS GEORGE EVP CSO President Regeneron Re -1,457 $109.29 -0.16%
2/15/2012 McCorkle Douglas S VP Controller and Asst Treasur -9,097 $111.08 -62.96%
2/15/2012 SCHLEIFER LEONARD S President & CEO -6,257 $111.01 -1.59%
2/15/2012 GILMAN ALFRED G Director -26,734 $109.56 -100.00%
2/15/2012 STAHL NEIL SVP Research and Development S -19,057 $107.79 -23.76%
2/15/2012 STAHL NEIL SVP Research and Development S -2,025 $108.09 -3.31%
2/14/2012 GILMAN ALFRED G Director -2,028 $111.01 -13.52%
2/14/2012 GILMAN ALFRED G Director 15,000 $9.17 115.63%
2/14/2012 GILMAN ALFRED G Director -1,238 $111.01 -4.43%
2/14/2012 GOLDSTEIN JOSEPH L Director -5,000 $110.02 -100.00%
2/14/2012 GOLDSTEIN JOSEPH L Director -10,000 $110.02 -100.00%
2/14/2012 STAHL NEIL SVP Research and Development S 50,000 $16.80 55.36%
2/14/2012 SCHLEIFER LEONARD S President & CEO -1,801 $111.01 -0.46%
2/14/2012 SCHLEIFER LEONARD S President & CEO 15,384 $13.00 4.06%
2/14/2012 SCHLEIFER LEONARD S President & CEO -95,016 $111.01 -20.04%
2/14/2012 SCHLEIFER LEONARD S President & CEO -43,757 $111.01 -8.45%
2/14/2012 SCHLEIFER LEONARD S President & CEO 250,000 $19.43 93.36%
2/14/2012 SCHLEIFER LEONARD S President & CEO -95,429 $111.01 -26.27%
2/14/2012 SCHLEIFER LEONARD S President & CEO -27,475 $111.01 -7.03%
2/14/2012 SCHLEIFER LEONARD S President & CEO 234,616 $13.00 150.33%
2/14/2012 STAHL NEIL SVP Research and Development S -7,566 $111.01 -5.39%
2/14/2012 STAHL NEIL SVP Research and Development S -21,352 $111.01 -16.08%
2/14/2012 McCorkle Douglas S VP Controller and Asst Treasur -5,864 $111.01 -28.87%
2/14/2012 McCorkle Douglas S VP Controller and Asst Treasur -2,269 $111.01 -10.05%
2/14/2012 McCorkle Douglas S VP Controller and Asst Treasur 15,000 $16.80 197.81%
2/14/2012 McCorkle Douglas S VP Controller and Asst Treasur -4,807 $111.01 -38.80%
2/14/2012 McCorkle Douglas S VP Controller and Asst Treasur -3,048 $111.01 -19.74%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (REGN), click here.
Marketplace
Trading Center